Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Accounts Payables (2018 - 2025)

Volitionrx filings provide 11 years of Accounts Payables readings, the most recent being $2.9 million for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 5.52% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a 5.52% increase, with the full-year FY2025 number at $2.9 million, up 5.52% from a year prior.
  • Accounts Payables hit $2.9 million in Q4 2025 for Volitionrx, down from $3.1 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $3.5 million in Q1 2024 to a low of $1.1 million in Q2 2021.
  • Median Accounts Payables over the past 5 years was $2.9 million (2025), compared with a mean of $2.7 million.
  • Biggest five-year swings in Accounts Payables: soared 140.24% in 2022 and later fell 29.78% in 2025.
  • Volitionrx's Accounts Payables stood at $1.5 million in 2021, then surged by 97.28% to $3.0 million in 2022, then increased by 5.53% to $3.2 million in 2023, then dropped by 13.86% to $2.8 million in 2024, then rose by 5.52% to $2.9 million in 2025.
  • The last three reported values for Accounts Payables were $2.9 million (Q4 2025), $3.1 million (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.